Monkeypox may be transmitted through fecal microbiota transplantation
Because of this risk, the FDA determined that additional protections are required for any investigational use of fecal microbiota transplantation if it involves stool donated on or after March 15, 2022.
The FDA advised in an Aug. 22 safety alert that fecal microbiota transplantation (FMT) has the potential to transmit monkeypox virus.
Because of this risk, the FDA determined that additional protections are required for any investigational use of FMT if it involves stool donated on or after March 15, 2022. These additional protections include donor screening with questions aimed at identifying donors at high risk for monkeypox or those who may be currently or recently infected.
As for blood donation establishments, the FDA does not recommend that they ask donors additional, specific questions about possible exposure to monkeypox virus, given the robustness of the existing safeguards for blood safety.